scholarly article | Q13442814 |
P50 | author | Thanh D Do | Q56152984 |
Anthony Nicholls | Q4773189 | ||
P2093 | author name string | Brian P Kelley | |
Stephen D Warren | |||
Gregory L Warren | |||
P433 | issue | 23-24 | |
P921 | main subject | drug discovery | Q1418791 |
P304 | page(s) | 1270-1281 | |
P577 | publication date | 2012-06-21 | |
P1433 | published in | Drug Discovery Today | Q3040085 |
P1476 | title | Essential considerations for using protein-ligand structures in drug discovery | |
P478 | volume | 17 |
Q64168599 | A Diverse Benchmark Based on 3D Matched Molecular Pairs for Validating Scoring Functions |
Q28541718 | A structure-based model for predicting serum albumin binding |
Q35201046 | An integrated approach to knowledge-driven structure-based virtual screening |
Q54275024 | An integrated suite of modeling tools that empower scientists in structure- and property-based drug design. |
Q41940007 | Automating crystallographic structure solution and refinement of protein-ligand complexes. |
Q125738545 | Best Practices for Alchemical Free Energy Calculations [Article v1.0] |
Q42119055 | CREDO: a structural interactomics database for drug discovery |
Q30543685 | CSAR Benchmark Exercise 2011–2012: Evaluation of Results from Docking and Relative Ranking of Blinded Congeneric Series |
Q30619853 | CSAR data set release 2012: ligands, affinities, complexes, and docking decoys |
Q90407504 | Comprehensive Assessment of Torsional Strain in Crystal Structures of Small Molecules and Protein-Ligand Complexes using ab Initio Calculations |
Q39138265 | Computer-aided drug design to explore cyclodextrin therapeutics and biomedical applications. |
Q47611051 | Conformational Aspects in the Design of Inhibitors for Serine Hydroxymethyltransferase (SHMT): Biphenyl, Aryl Sulfonamide, and Aryl Sulfone Motifs. |
Q57984891 | Conformational investigation of the structure-activity relationship of GdFFD and its analogues on an achatin-like neuropeptide receptor of Aplysia californica involved in the feeding circuit |
Q46289927 | Crystal structure of type II NADH:quinone oxidoreductase from Caldalkalibacillus thermarum with an improved resolution of 2.15 Å. |
Q36152480 | Detecting the native ligand orientation by interfacial rigidity: SiteInterlock |
Q39317819 | Docking-undocking combination applied to the D3R Grand Challenge 2015. |
Q92610924 | Experimental and Computational Evaluation of Piperonylic Acid Derived Hydrazones Bearing Isatin Moieties as Dual Inhibitors of Cholinesterases and Monoamine Oxidases |
Q39027957 | Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations |
Q93080641 | Finding High-Quality Metal Ion-Centric Regions Across the Worldwide Protein Data Bank |
Q57204523 | Homology-based loop modeling yields more complete crystallographic protein structures |
Q54327473 | How Diverse Are the Protein-Bound Conformations of Small-Molecule Drugs and Cofactors? |
Q64092935 | ImmtorLig_DB: repertoire of virtually screened small molecules against immune receptors to bolster host immunity |
Q28831160 | Improved ligand geometries in crystallographic refinement using AFITT in PHENIX |
Q36329335 | Improving the accuracy of high-throughput protein-protein affinity prediction may require better training data |
Q28829862 | Kinetic barriers in the isomerization of substituted ureas: implications for computer-aided drug design |
Q34657185 | Learning from our mistakes: The ‘unknown knowns’ in fragment screening |
Q30971961 | Low-Quality Structural and Interaction Data Improves Binding Affinity Prediction via Random Forest. |
Q30371590 | Models of protein-ligand crystal structures: trust, but verify |
Q39038055 | Molecular dynamics simulations reveal structural insights into inhibitor binding modes and functionality in human Group IIA phospholipase A2. |
Q36099648 | Novel ligands of Choline Acetyltransferase designed by in silico molecular docking, hologram QSAR and lead optimization |
Q30277026 | Outcome of the First wwPDB/CCDC/D3R Ligand Validation Workshop |
Q53185669 | Predicting the relative binding affinity of mineralocorticoid receptor antagonists by density functional methods |
Q50051009 | Protein-ligand interfaces are polarized: discovery of a strong trend for intermolecular hydrogen bonds to favor donors on the protein side with implications for predicting and designing ligand complexes. |
Q36092094 | Quality Issues with Public Domain Chemogenomics Data. |
Q28534778 | SWEETLEAD: an in silico database of approved drugs, regulated chemicals, and herbal isolates for computer-aided drug discovery |
Q35009886 | Structural characterization of the binding interactions of various endogenous estrogen metabolites with human estrogen receptor α and β subtypes: a molecular modeling study |
Q36267055 | Structure-Based Virtual Screening |
Q92635049 | Structure-Based Virtual Screening, Molecular Dynamics and Binding Free Energy Calculations of Hit Candidates as ALK-5 Inhibitors |
Q55669302 | Superior Performance of the SQM/COSMO Scoring Functions in Native Pose Recognition of Diverse Protein–Ligand Complexes in Cognate Docking. |
Q46014526 | The application of statistical methods to cognate docking: A path forward? |
Q42538022 | The good, the bad and the dubious: VHELIBS, a validation helper for ligands and binding sites |
Q86433361 | Towards predictive docking at aminergic G-protein coupled receptors |
Q55059617 | Validation of ligands in macromolecular structures determined by X-ray crystallography |
Q36015308 | Vinardo: A Scoring Function Based on Autodock Vina Improves Scoring, Docking, and Virtual Screening |
Q93239299 | qFit-ligand Reveals Widespread Conformational Heterogeneity of Drug-Like Molecules in X-Ray Electron Density Maps |
Search more.